Loading...

VERV - Verve Therapeutics

Analyst Coverage Initiated Signal for 06-17-2022
Analyst Coverage Initiated: VERV rating Outperform by BMO Capital Markets
Price Target: $48


Loading Chart VERV

Stock Signal Information


Signal

Analyst Coverage Initiated: VERV rating Outperform by BMO Capital Markets
Price Target: $48
Report Date: 06-17-2022
Symbol: VERV - Verve Therapeutics
Sector:
Industry:
Analyst Coverage Initiated: VERV rating Outperform by BMO Capital Markets
Price Target: $48

  VERV Technical Analysis

VERV, Verve Therapeutics

VERV Verve Therapeutics Logo Image

,